[Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].
The Austrian Alzheimer Society developed evidence-based guidelines based on a systematic literature search and criteria-guided assessment with subsequent transparent determination of grades of clinical recommendation. The authors evaluated currently available therapeutic approaches for the most common forms of dementia and focused on diagnosis and pharmacological intervention, taking into consideration the situation in Austria. The purpose of these guidelines is the rational and cost-effective use of diagnostic and therapeutic measures in dementing illnesses. Users are physicians and all other providers of care for patients with dementia in Austria.
Schmidt
Reinhold
R
Universitätsklinik für Neurologie, Medizinische Universität Graz, reinhold.schmidt@medunigraz.at
Marksteiner
Michael
M
Dal-Bianco
Peter
P
Ransmayr
G
G
Bancher
C
C
Benke
T
T
Wancata
J
J
Fischer
P
P
Leblhuber
C F
CF
Psota
G
G
Ackerl
M
M
Alf
C
C
Berek
K
K
Croy
A
A
Delazer
M
M
Fasching
P
P
Frühwald
T
T
Fruhwürth
G
G
Fuchs-Nieder
B
B
Gatterer
G
G
Grossmann
J
J
Hinterhuber
H
H
Iglseder
B
B
Imarhiagbe
D
D
Jagsch
C
C
Jellinger
K
K
Kalousek
M
M
Kapeller
P
P
Ladurner
G
G
Lampl
C
C
Lechner
A
A
Lingg
A
A
Nakajima
T
T
Rainer
M
M
Reisecker
F
F
Spatt
J
J
Walch
T
T
Uranüs
M
M
Walter
A
A
D000368:Aged; D000369:Aged, 80 and over; D000596:Amino Acids / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy; D003430:Cross-Sectional Studies; D003704:Dementia / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D020441:Ginkgo biloba; D006801:Humans; D015994:Incidence; D008019:Life Style; D008134:Long-Term Care; D008297:Male; D055118:Medication Adherence; D008559:Memantine / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D018697:Nootropic Agents / Q000627:therapeutic use*; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use; D011157:Population Dynamics; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D000596:Amino Acids; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D010936:Plant Extracts; D011619:Psychotropic Drugs; C006952:cerebrolysin; D008559:Memantine